KIR2DS1: A Protein Involved in Immune Function and Cancer Development

Target Name: KIR2DS1

NCBI ID: G3806

KIR2DS1

KIR2DS1: A Protein Involved in Immune Function and Cancer Development

KIR2DS1 (KI2S1_HUMAN) is a protein that is expressed in most tissues of the human body. It is a key regulator of the immune response and has been implicated in a number of diseases, including cancer. In recent years, researchers have been interested in studying KIR2DS1 as a potential drug target or biomarker because of its unique structure and biology.

The KIR2DS1 protein is composed of 251 amino acid residues and has a molecular weight of 31 kDa. It is located in the cytoplasm and is involved in the regulation of various cellular processes, including cell adhesion, migration, and the response to stimuli. KIR2DS1 is a G protein-coupled receptor (GPCR), which means that it interacts with intracellular signaling molecules that are derived from the G protein family.

KIR2DS1 has been shown to play a role in the regulation of immune cell function and has been implicated in the development and progression of a number of diseases. For example, KIR2DS1 has been shown to be involved in the regulation of T cell development and function. KIR2DS1 has been shown to promote the growth and survival of T cells, which are a critical component of the immune system.

In addition to its role in T cell development, KIR2DS1 has also been shown to be involved in the regulation of cell signaling pathways that are important for the growth and survival of cancer cells. For example, KIR2DS1 has been shown to play a role in the regulation of the PI3K/Akt signaling pathway, which is important for the growth and survival of cancer cells.

KIR2DS1 has also been shown to be involved in the regulation of cell adhesion and migration. For example, KIR2DS1 has been shown to promote the adhesion of cancer cells to the extracellular matrix (ECM), which is important for the development and progression of cancer. In addition, KIR2DS1 has been shown to play a role in the regulation of cell migration, which is important for the formation of cancer stem cells.

In conclusion, KIR2DS1 is a unique and highly-regulated protein that has important roles in the regulation of immune cell function and the development and progression of cancer. As a potential drug target or biomarker, KIR2DS1 is of great interest to researchers because of its unique structure and biology. Further research is needed to fully understand the role of KIR2DS1 in these processes and to develop effective treatments for a variety of diseases.

Protein Name: Killer Cell Immunoglobulin Like Receptor, Two Ig Domains And Short Cytoplasmic Tail 1

Functions: Receptor on natural killer (NK) cells for some HLA-C alleles such as w6. Does not inhibit the activity of NK cells

The "KIR2DS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KIR2DS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets